FibroBiologics (FBLG) Stock Price, Quote, News & History | Benzinga

FibroBiologics Inc (FBLG) Stock Price, Quote, News & History

FBLGNASDAQ

Trade with Public

Trade with Public

$0.9500

-0.06-5.94%

Last update: Jun 9, 1:39 PM

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$0.99

Close

-

Volume / Avg.

105.09K / 433.35K

Day Range

$0.95 - $1.01

52 Wk Range

0.95 - 19.80

Market Cap

$4.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

29

Short Interest

4.86%

Days to Cover

1

Recent Fibrobiologics Inc News

EXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trial

FibroBiologics Inc. (NASDAQ: FBLG) reports enrolling first patients in its Phase 1/2 trial for CYWC628, a fibroblast-based therapy targeting diabetic foot ulcers.

Mohit Manghnani

EXCLUSIVE: FibroBiologics Targets 2026 Data Readout After Trial Progress For Diabetic Foot Ulcer Study

FibroBiologics releases CYWC628 batch for DFU trial, clears cGMP checks, prepares enrollment; interim data expected in Q3 2026.

Vandana Singh

EXCLUSIVE: FibroBiologics Moves Forward With Human Trial For Diabetic Foot Ulcer Therapy

FibroBiologics completes first CYWC628 batch for diabetic foot ulcers trials, advances pipeline amid stock drop and recent reverse split.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-15.48M

Investing Cash Flow (TTM)

-219.00K

Financing Cash Flow (TTM)

8.52M

Free Cash Flow (TTM)

-15.70M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-7.19M

Analyst Trends and Forecast

2

Jan

2

Feb

1

Mar

1

Apr

0

0

0

0

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$6.20M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.00

Earnings Yield % (TTM)

-702.00%

Earnings Yield % (FWD)

-340.00%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.50

Company Debt

Total Debt

$246.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$1.48M

Debt to Equity

0.95

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$3.48M

Key Statistics

Open

$0.99

Close

-

Volume / Avg.

105.09K / 433.35K

Day Range

$0.95 - $1.01

52 Wk Range

0.95 - 19.80

Market Cap

$4.95M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

29

Short Interest

4.86%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy FibroBiologics (FBLG) stock?

A

You can purchase shares of FibroBiologics (NASDAQ:FBLG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are FibroBiologics (FBLG) competitors?

A

There are no as such competitors for FibroBiologics.

Q

What is the forecast, or price target, for FibroBiologics (FBLG) stock?

A

FibroBiologics has a consensus price target of $12.00.

Q

What is the current price for FibroBiologics (FBLG)?

A

The stock price for FibroBiologics (NASDAQ: FBLG) is $0.95 last updated June 9, 2026 at 1:39 PM EDT.

Q

Does FibroBiologics (FBLG) pay a dividend?

A

There are no upcoming dividends for FibroBiologics.

Q

When is FibroBiologics (NASDAQ:FBLG) reporting earnings?

A

FibroBiologics does not have any upcoming earnings scheduled.

Q

Is FibroBiologics (FBLG) going to split?

A

There is no upcoming split for FibroBiologics.

Q

What sector and industry does FibroBiologics (FBLG) operate in?

A

FibroBiologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.